Search

everythinglearnresearchcommunity

for

Search:↓

Genomic profiling for myeloid cancers can find important inherited mutations, but it's challenging when these mutations aren't related to the patient's symptoms.

PSA screening's effectiveness in reducing prostate cancer deaths can vary based on trial design and participant compliance.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

Finasteride reduces prostate size, improves urination, and slows prostate cancer progression.

Regular endoscopic checks are crucial for Cronkhite-Canada syndrome patients to catch potential cancers early.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Taking 1mg of finasteride daily for hair loss can lower PSA levels by 40-50%, so to keep PSA effective as a cancer screening tool, the PSA value should be doubled during treatment.

Cronkhite-Canada syndrome is a rare, non-inherited condition causing various symptoms like polyps, hair loss, and weight loss.

Corticosteroids improved symptoms in a man with Cronkhite-Canada Syndrome.

A man with Cronkhite-Canada syndrome improved significantly with immunosuppressive therapy.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Finasteride use may increase the risk of male breast cancer.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Breast cancer patients need strong psychological support to improve their quality of life.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

Cancer survivors need better skin care to improve their quality of life.

Some side effects of breast cancer chemotherapy, like neuropathy and nail loss, can last long after treatment.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Male pattern baldness is linked to a higher risk of certain skin cancers, especially on the scalp.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

The number of advanced breast cancer cases in women under 40 has increased, but the overall numbers are still low.

Higher cholesterol levels increase aggressive prostate cancer risk.

Male pattern baldness may predict prostate cancer risk.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Men with male pattern baldness have a higher risk of certain skin cancers, especially on the scalp.